These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33258174)

  • 1. Influence of donor-transmitted coronary artery disease on long-term outcomes after heart transplantation - a retrospective study.
    Lechiancole A; Vendramin I; Sponga S; Sappa R; Zanuttini D; Spedicato L; Ferrara V; Di Nora C; Livi U
    Transpl Int; 2021 Feb; 34(2):281-289. PubMed ID: 33258174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of cardiac allograft vasculopathy: Importance of the International Society for Heart and Lung Transplantation angiographic grading scale.
    Van Keer JM; Van Aelst LNL; Rega F; Droogne W; Voros G; Meyns B; Vanhaecke J; Emonds MP; Janssens S; Naesens M; Van Cleemput J
    J Heart Lung Transplant; 2019 Nov; 38(11):1189-1196. PubMed ID: 31543298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.
    Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease.
    Gao HZ; Hunt SA; Alderman EL; Liang D; Yeung AC; Schroeder JS
    J Am Coll Cardiol; 1997 Mar; 29(3):623-9. PubMed ID: 9060902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Coronary Artery Calcification in the Donor Heart on Transmitted Coronary Artery Disease in Heart Transplant Recipients.
    Kimura Y; Seguchi O; Iwasaki K; Toda K; Kikuchi N; Matsuda S; Kumai Y; Kuroda K; Wada K; Matsumoto Y; Fukushima S; Yanase M; Fujita T; Kobayashi J; Fukushima N
    Circ J; 2018 Nov; 82(12):3021-3028. PubMed ID: 30270311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The policy of placing older donors into older recipients: is it worth the risk?
    Tehrani YS; Yu Z; Luu M; Liou F; Rafiei M; Hamilton M; Kobashigawa JA
    Clin Transplant; 2014 Jul; 28(7):802-7. PubMed ID: 24801014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
    Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
    Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-term results of heart transplantation using donors over 63 years of age.
    Potapov EV; Loebe M; Hübler M; Musci M; Hummel M; Weng Y; Hetzer R
    Transplantation; 1999 Dec; 68(12):1834-8. PubMed ID: 10628759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation.
    Reich HJ; Kobashigawa JA; Aintablian T; Ramzy D; Kittleson MM; Esmailian F
    Tex Heart Inst J; 2018 Feb; 45(1):17-22. PubMed ID: 29556146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
    Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
    BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.
    Asleh R; Briasoulis A; Smith B; Lopez C; Alnsasra H; Pereira NL; Edwards BS; Clavell AL; Stulak JM; Locker C; Kremers WK; Daly RC; Lerman A; Kushwaha SS
    J Card Fail; 2021 May; 27(5):542-551. PubMed ID: 33962742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients.
    Li H; Tanaka K; Anzai H; Oeser B; Lai D; Kobashigawa JA; Tobis JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2470-6. PubMed ID: 16781375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary atherosclerosis of the donor heart--impact on early graft failure.
    Grauhan O; Siniawski H; Dandel M; Lehmkuhl H; Knosalla C; Pasic M; Weng YG; Hetzer R
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):634-8. PubMed ID: 17702594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart transplantation with donors fifty years of age and older.
    Blanche C; Kamlot A; Blanche DA; Kearney B; Magliato KE; Czer LS; Trento A
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):810-5. PubMed ID: 11986611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric heart transplantation recipients ≥7 years of age receiving donors with pre-existing coronary atherosclerosis showed progressive coronary artery disease.
    Kim MJ; Yu JJ; Cha S; Baek JS; Choi ES; Kwon BS; Park CS; Yun TJ; Kim YH
    Cardiol Young; 2022 Jul; 32(7):1104-1111. PubMed ID: 34565492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience.
    Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
    Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after heart transplantation from older donor age: expanding the donor pool.
    Prieto D; Correia P; Baptista M; Antunes MJ
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):672-8. PubMed ID: 25009213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients undergoing transplantation with older donor hearts.
    Drinkwater DC; Laks H; Blitz A; Kobashigawa J; Sabad A; Moriguchi J; Hamilton M
    J Heart Lung Transplant; 1996 Jul; 15(7):684-91. PubMed ID: 8820784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.